MedTrace Logo

A Five-Year Quality of Life Study for Cancer Patients

NCT01539148 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2013-05-03

No results posted yet for this study

Summary

The investigator is looking for patients who have been diagnosed with stage 1-4 cancer to enroll in a five year Quality of Life clinical trial study in which the participant has previously elected to use Insulin Potentiation Targeted Low Dose (IPTLD) as a means to treat their illness. This study is a quality of life study and not a treatment study. Participants participating in the study will be asked to complete quality of life questionnaires. The questionnaires completed by the patients will measure mood, energy level, ability to function, level of pain, and other measures that indicate how a patient feels about the quality of their daily living.

Conditions

Sponsors & Collaborators

  • Best Answer for Cancer Foundation

    collaborator OTHER

  • Constantine A. Kotsanis

    lead INDUSTRY

Principal Investigators

  • Constantine A. Kotsanis, MD · The Kotsanis Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2015-03-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01539148 on ClinicalTrials.gov